Pub Date : 2019-06-11DOI: 10.11648/J.IJCOCR.20190402.13
M. Didier, Kyabu Véronique, M. Phillipe, M. Abdon, I. Julien
Tumors had been misdiagnosed and under- documented for longtime in Africa. The Democratic Republic of Congo (DRC) has not any cancer registry available up today. The National Cancer Registry is an important tool to deal with cancer management, especially for the National Cancer Plan and cancer prevention. The African Cancer Registry Network (AFCRN) is trying to help many Countries to hold their national Registries in hope to provide tumors’ data. Despite National Cancer Registry, hospital Registries can be used for preliminary researches. This is a retrospective study performed to determine epidemiological and clinical data of tumors in Lubumbashi City, the second city in DRC, especially in the mines’ hospital during the period from 2007 to 2017. The authors collected data from 350 patients aged from 2 and 94 years. The average age was 46.3 ± 17.9 years. There were 299 Females and 51 males; means 85.4 vs 14.6%. Tumors of the female reproductive system accounted for 72.9%. Diagnosis was made by echography in 59.7% of cases. Palliative care was the main treatment in 51% of cases. This study has enlightened the fact that tumors are a serious problem of health in the Democratic Republic of Congo and there are many challenges to improve cancer survival in this country.
长期以来，肿瘤在非洲一直被误诊和记录不足。刚果民主共和国(DRC)目前没有任何癌症登记。国家癌症登记是处理癌症管理的重要工具，特别是对于国家癌症计划和癌症预防。非洲癌症登记网络(AFCRN)正试图帮助许多国家建立他们的国家登记处，以期提供肿瘤数据。尽管有国家癌症登记处，但医院登记处可用于初步研究。这是一项回顾性研究，旨在确定2007年至2017年期间刚果民主共和国第二大城市卢本巴希市，特别是矿山医院的肿瘤流行病学和临床数据。作者收集了350名患者的数据，年龄从2岁到94岁不等。平均年龄46.3±17.9岁。其中女性299人，男性51人;平均值85.4 vs 14.6%。女性生殖系统肿瘤占72.9%。超声诊断率为59.7%。51%的病例以姑息治疗为主。这项研究揭示了这样一个事实:肿瘤在刚果民主共和国是一个严重的健康问题，在这个国家，提高癌症存活率存在许多挑战。
{"title":"Tumors Registry in Low Income Countries’ Hospital: A Retrospective Study of 350 Cases in the Democratic Republic of Congo from 2007 to 2017","authors":"M. Didier, Kyabu Véronique, M. Phillipe, M. Abdon, I. Julien","doi":"10.11648/J.IJCOCR.20190402.13","DOIUrl":"https://doi.org/10.11648/J.IJCOCR.20190402.13","url":null,"abstract":"Tumors had been misdiagnosed and under- documented for longtime in Africa. The Democratic Republic of Congo (DRC) has not any cancer registry available up today. The National Cancer Registry is an important tool to deal with cancer management, especially for the National Cancer Plan and cancer prevention. The African Cancer Registry Network (AFCRN) is trying to help many Countries to hold their national Registries in hope to provide tumors’ data. Despite National Cancer Registry, hospital Registries can be used for preliminary researches. This is a retrospective study performed to determine epidemiological and clinical data of tumors in Lubumbashi City, the second city in DRC, especially in the mines’ hospital during the period from 2007 to 2017. The authors collected data from 350 patients aged from 2 and 94 years. The average age was 46.3 ± 17.9 years. There were 299 Females and 51 males; means 85.4 vs 14.6%. Tumors of the female reproductive system accounted for 72.9%. Diagnosis was made by echography in 59.7% of cases. Palliative care was the main treatment in 51% of cases. This study has enlightened the fact that tumors are a serious problem of health in the Democratic Republic of Congo and there are many challenges to improve cancer survival in this country.","PeriodicalId":158614,"journal":{"name":"International Journal of Clinical Oncology and Cancer Research","volume":"46 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115460136","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-06-11DOI: 10.11648/J.IJCOCR.20190402.12
Azka Ali, R. Bosse, B. Doonan, P. Narayan, Grant Jester, J. DeLaune, Jacob Barish, Samantha Welniak, H. Norton, C. Heldermon
First introduced in 1963, ommaya reservoirs (OmRs) are indwelling intraventricular catheters used for decompression of hydrocephalus, antibiotics, and chemotherapy delivery. They are important alternatives when lumbar punctures are not practical or when long-term administration of medications is needed. Despite being used for over 50 years, placement of these devices can still contribute to significant morbidity and mortality. We performed a single-center retrospective review at the University of Florida Cancer Center evaluating OmR related complications in patients in whom OmR was placed for chemotherapy. We also conducted a systematic review of OmR related and LP complications in setting of chemotherapy delivery. 13 patients met criteria for inclusion in this retrospective study. Time points evaluated for complications were: placement, up to 6 months, 6-12 months, > 12 months, removal and post-discharge. Our institutional data showed a complicated rate of <7% at each time point. For systematic review, 38 studies were reviewed for OmR data, and 8 studies were reviewed for LP data. Infectious complications were more prevalent in OmR studies with statistical significance (p=0.0017), whereas noninfectious complications were more prevalent in LP studies with statistical significance (p=0.0004). This study compared complication rates from infectious and non-infectious sources between patients receiving intrathecal chemotherapy through Ommaya reservoirs versus lumbar puncture. OmR can be very useful in long-term administration of medication, and the relatively high complication rate (especially infectious) can be deemed an acceptable risk for patient population with high morbidity.
{"title":"Ommaya Reservoir Related Complications: A Single Center Experience and Review of Current Literature","authors":"Azka Ali, R. Bosse, B. Doonan, P. Narayan, Grant Jester, J. DeLaune, Jacob Barish, Samantha Welniak, H. Norton, C. Heldermon","doi":"10.11648/J.IJCOCR.20190402.12","DOIUrl":"https://doi.org/10.11648/J.IJCOCR.20190402.12","url":null,"abstract":"First introduced in 1963, ommaya reservoirs (OmRs) are indwelling intraventricular catheters used for decompression of hydrocephalus, antibiotics, and chemotherapy delivery. They are important alternatives when lumbar punctures are not practical or when long-term administration of medications is needed. Despite being used for over 50 years, placement of these devices can still contribute to significant morbidity and mortality. We performed a single-center retrospective review at the University of Florida Cancer Center evaluating OmR related complications in patients in whom OmR was placed for chemotherapy. We also conducted a systematic review of OmR related and LP complications in setting of chemotherapy delivery. 13 patients met criteria for inclusion in this retrospective study. Time points evaluated for complications were: placement, up to 6 months, 6-12 months, > 12 months, removal and post-discharge. Our institutional data showed a complicated rate of <7% at each time point. For systematic review, 38 studies were reviewed for OmR data, and 8 studies were reviewed for LP data. Infectious complications were more prevalent in OmR studies with statistical significance (p=0.0017), whereas noninfectious complications were more prevalent in LP studies with statistical significance (p=0.0004). This study compared complication rates from infectious and non-infectious sources between patients receiving intrathecal chemotherapy through Ommaya reservoirs versus lumbar puncture. OmR can be very useful in long-term administration of medication, and the relatively high complication rate (especially infectious) can be deemed an acceptable risk for patient population with high morbidity.","PeriodicalId":158614,"journal":{"name":"International Journal of Clinical Oncology and Cancer Research","volume":"48 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127230117","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-05-30DOI: 10.11648/J.IJCOCR.20190401.11
M. Didier, Kyabu Véronique, M. Philippe, Mukalay Abdon, C. Joseph, Kalenga Prosper, I. Julien
The objective of this study is to show that the presence of koilocytosis on the cervical smear is the only possibility to detect Papillomavirus infection in cervical intra-epithelial neoplasia in women living in Lubumbashi. This is a cross-sectional analytical study on the data collected from the register of women who participated in the cervix lesion screening campaign organized in Lubumbashi in March 2012 by the Congolese League Against Cancer. A total of 545 women with cervical lesions have been selected. The following results were observed: the frequency of HPV infection is 35% in Lubumbashi women. The risk of developing intraepithelial neoplasia is 38.3 times higher in women infected with HPV compared to uninfected ones (OR = 38.3, 95% CI = 16.3-90.3). HPV is predominantly present in intraepithelial neoplasia (92.7%) and this regardless of their grade: 91.9% for low-grade neoplasia and 95% for high-grade neoplasia. HPV is found in both older women and older women, respectively in 45% of women aged less than 36 years and in 55% of women aged over 36 years old. This study shows that it is necessary to put in place adequate means for the detection of HPV in order to contribute to the fight against cervical cancer in Lubumbashi.
本研究的目的是表明，宫颈涂片上有白细胞增多症是卢本巴希妇女宫颈上皮内瘤变中检测乳头瘤病毒感染的唯一可能性。这是对2012年3月在卢本巴希参加刚果抗癌联盟组织的子宫颈病变筛查运动的妇女登记册收集的数据进行的横断面分析研究。共有545名患有宫颈病变的妇女被选中。观察到以下结果:卢本巴希妇女的HPV感染频率为35%。与未感染HPV的女性相比，感染HPV的女性发生上皮内瘤变的风险高38.3倍(OR = 38.3, 95% CI = 16.3-90.3)。HPV主要存在于上皮内瘤变中(92.7%)，与级别无关:低级别瘤变为91.9%，高级别瘤变为95%。HPV在老年妇女和老年妇女中均有发现，分别在45%的36岁以下妇女和55%的36岁以上妇女中发现。这项研究表明，有必要采取适当的手段检测人乳头瘤病毒，以便为卢本巴希防治宫颈癌作出贡献。
{"title":"Human Papillomavirus and Cervical Intra-Epithelial Neoplasia: Epidemiological and Cytological Study in Lubumbashi Women","authors":"M. Didier, Kyabu Véronique, M. Philippe, Mukalay Abdon, C. Joseph, Kalenga Prosper, I. Julien","doi":"10.11648/J.IJCOCR.20190401.11","DOIUrl":"https://doi.org/10.11648/J.IJCOCR.20190401.11","url":null,"abstract":"The objective of this study is to show that the presence of koilocytosis on the cervical smear is the only possibility to detect Papillomavirus infection in cervical intra-epithelial neoplasia in women living in Lubumbashi. This is a cross-sectional analytical study on the data collected from the register of women who participated in the cervix lesion screening campaign organized in Lubumbashi in March 2012 by the Congolese League Against Cancer. A total of 545 women with cervical lesions have been selected. The following results were observed: the frequency of HPV infection is 35% in Lubumbashi women. The risk of developing intraepithelial neoplasia is 38.3 times higher in women infected with HPV compared to uninfected ones (OR = 38.3, 95% CI = 16.3-90.3). HPV is predominantly present in intraepithelial neoplasia (92.7%) and this regardless of their grade: 91.9% for low-grade neoplasia and 95% for high-grade neoplasia. HPV is found in both older women and older women, respectively in 45% of women aged less than 36 years and in 55% of women aged over 36 years old. This study shows that it is necessary to put in place adequate means for the detection of HPV in order to contribute to the fight against cervical cancer in Lubumbashi.","PeriodicalId":158614,"journal":{"name":"International Journal of Clinical Oncology and Cancer Research","volume":"21 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114503909","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.11648/j.ijcocr.20220701.12
Genu Takahashi, Nanako Okuno, Kyotaro Yoshino, T. Hirata, Chihiro Kobayashi, Akira Mori, M. Watada
: Colorectal cancer affects a large number of people. There is an urgent need to develop novel treatments for this disease. In recent years, research on medical applications of atmospheric low temperature plasma (ALTP) has been actively conducted
{"title":"The Effects of Plasma-Activated Saline and Medium on Colorectal Cancer in Rat Models and the Human Colon Adenocarcinoma Cell Line COLO 205","authors":"Genu Takahashi, Nanako Okuno, Kyotaro Yoshino, T. Hirata, Chihiro Kobayashi, Akira Mori, M. Watada","doi":"10.11648/j.ijcocr.20220701.12","DOIUrl":"https://doi.org/10.11648/j.ijcocr.20220701.12","url":null,"abstract":": Colorectal cancer affects a large number of people. There is an urgent need to develop novel treatments for this disease. In recent years, research on medical applications of atmospheric low temperature plasma (ALTP) has been actively conducted","PeriodicalId":158614,"journal":{"name":"International Journal of Clinical Oncology and Cancer Research","volume":"8 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128317747","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
: Objective: The aim of this study was to explore the effect of predictive nursing intervention on the gastrointestinal side effects of I-131 re-treatment in patients with differentiated thyroid cancer (DTC). Methods: From January 2017 to August 2018, we invited patient with DTC who received I-131 re-treatment to enroll in this study. The participants were randomly assigned to control or predictive nursing intervention groups using a random number table. The primary outcomes were the incidence of gastrointestinal side effects and degree of patient satisfaction with respect to nursing. Patients in the intervention group received predictive nursing intervention, and patients in the control group received common nursing intervention. Result: A total of 69 patients were enrolled in the study. In patient characteristic, the gender, age and disease status were no significantly different for the participants in two groups. In addition, intervention group participants had less gastrointestinal side effect events, including nausea, vomiting and anorexia (10 vs 3, 8 vs 1, 12 vs 2). In nursing satisfaction assessment, intervention group participants provided better outcome in nursing satisfaction assessment compared with control group, that they provided most very satisfied assessment to predictive nursing intervention. Conclusion: Predictive nursing helped decrease the incidence of gastrointestinal side effects and improved patient satisfaction with nursing. Predictive nursing may be effective in DTC patients receiving I-131 re-treatment.
目的:探讨预测性护理干预对分化型甲状腺癌(DTC)患者I-131再治疗胃肠道不良反应的影响。方法:2017年1月至2018年8月，我们邀请接受I-131再治疗的DTC患者加入本研究。采用随机数字表法将参与者随机分为对照组和预见性护理干预组。主要结果是胃肠道副作用的发生率和患者对护理的满意度。干预组患者接受预测性护理干预，对照组患者接受常规护理干预。结果:共有69例患者入组研究。在患者特征上，两组患者的性别、年龄、疾病状况无显著差异。此外，干预组患者恶心、呕吐、厌食等胃肠道不良反应发生率较低(10 vs 3, 8 vs 1, 12 vs 2)。在护理满意度评估中，干预组患者的护理满意度评估结果优于对照组，对预测性护理干预的满意度评价最高。结论:预测性护理有助于减少胃肠道不良反应的发生，提高患者对护理的满意度。预测性护理对接受I-131再治疗的DTC患者可能有效。
{"title":"Effect of Predictive Nursing Intervention on the Gastrointestinal Side Effects of I-131 Re-treatment in Patients with Differentiated Thyroid Cancer (DTC)","authors":"Miaoli Zhou, Yanlan Liu, Qingran Lin, Jinmei Xiong, Bin Guo, Hao Xu","doi":"10.11648/j.ijcocr.20220702.15","DOIUrl":"https://doi.org/10.11648/j.ijcocr.20220702.15","url":null,"abstract":": Objective: The aim of this study was to explore the effect of predictive nursing intervention on the gastrointestinal side effects of I-131 re-treatment in patients with differentiated thyroid cancer (DTC). Methods: From January 2017 to August 2018, we invited patient with DTC who received I-131 re-treatment to enroll in this study. The participants were randomly assigned to control or predictive nursing intervention groups using a random number table. The primary outcomes were the incidence of gastrointestinal side effects and degree of patient satisfaction with respect to nursing. Patients in the intervention group received predictive nursing intervention, and patients in the control group received common nursing intervention. Result: A total of 69 patients were enrolled in the study. In patient characteristic, the gender, age and disease status were no significantly different for the participants in two groups. In addition, intervention group participants had less gastrointestinal side effect events, including nausea, vomiting and anorexia (10 vs 3, 8 vs 1, 12 vs 2). In nursing satisfaction assessment, intervention group participants provided better outcome in nursing satisfaction assessment compared with control group, that they provided most very satisfied assessment to predictive nursing intervention. Conclusion: Predictive nursing helped decrease the incidence of gastrointestinal side effects and improved patient satisfaction with nursing. Predictive nursing may be effective in DTC patients receiving I-131 re-treatment.","PeriodicalId":158614,"journal":{"name":"International Journal of Clinical Oncology and Cancer Research","volume":"2 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129044665","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.11648/j.ijcocr.20220702.13
A. Bensalem, Abdellaziz Ammari, Chouaib Hellal, S. Bensalem, K. Bouzid, Nour El Houda Kellab, Houda Meguellati, Amina Boudraa, Asma Seghiri, O. Messalbi, Meryem Barani, Nour El Houda Sloula, Samia Kouartel, Asma Bououdina, Amira Sadou, Tarek Bendjeddou, Hiba Rais, Nour El Islam Mecheri, Nadjet Lachter, Meryem Boudjerda
{"title":"COVID-19 Vaccine Safety in Cancer Patients: A Single Center Experience","authors":"A. Bensalem, Abdellaziz Ammari, Chouaib Hellal, S. Bensalem, K. Bouzid, Nour El Houda Kellab, Houda Meguellati, Amina Boudraa, Asma Seghiri, O. Messalbi, Meryem Barani, Nour El Houda Sloula, Samia Kouartel, Asma Bououdina, Amira Sadou, Tarek Bendjeddou, Hiba Rais, Nour El Islam Mecheri, Nadjet Lachter, Meryem Boudjerda","doi":"10.11648/j.ijcocr.20220702.13","DOIUrl":"https://doi.org/10.11648/j.ijcocr.20220702.13","url":null,"abstract":"","PeriodicalId":158614,"journal":{"name":"International Journal of Clinical Oncology and Cancer Research","volume":"15 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133398122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
: Castleman’s Disease is a rare lymphoproliferative disorder of idiopathic etio-pathogenesis and was first described by Dr Benjamin Castleman in 1954. It is a rather rare disease entity in clinical practice. However, the incidence cannot be ignored. It may affect a single lymph node (Unicentric CD) or multiple lymph nodes throughout the body (Multicentric CD). Management depends upon the type and severity of the disease and early recognition of the condition. Our case report is that of a 60-year-old female patient with underlying comorbidities including type 2 diabetes mellitus, hypothyroidism who presented with complaints of generalized weakness, weight loss, hair loss, non-resolving muco-purulent rhinorrhea, bilateral pedal edema and multiple, non-tender, firm and mobile left sided Level I and II ‘AJCC’ cervical lymphadenopathy of >2cm which was later biopsied and diagnosed to be Castleman’s disease associated POEMS syndrome. The aim of this report is to consider CD as a differential diagnosis in patients presenting with similar clinical picture and early identification and treatment may provide a better prognosis. We would also like to highlight 3 take home points: 1) The significance of histology in differentiating it from other lymph proliferative conditions. 2) LN excision of the bothersome LN can be diagnostic and may be considered therapeutic to some extend even in MCD. 3) Steroid therapy has beneficial effects to control progression of the disease.
{"title":"A Case Report on Idiopathic-Multi-centric Castleman’s Disease Associated POEMS- Syndrome","authors":"Amritha Radhakrishnan Nair, Changaramkumarath Gichin, Deepa Pramod Raj Santhi, Moothiringode Chithrabhanu Savithri","doi":"10.11648/j.ijcocr.20220701.13","DOIUrl":"https://doi.org/10.11648/j.ijcocr.20220701.13","url":null,"abstract":": Castleman’s Disease is a rare lymphoproliferative disorder of idiopathic etio-pathogenesis and was first described by Dr Benjamin Castleman in 1954. It is a rather rare disease entity in clinical practice. However, the incidence cannot be ignored. It may affect a single lymph node (Unicentric CD) or multiple lymph nodes throughout the body (Multicentric CD). Management depends upon the type and severity of the disease and early recognition of the condition. Our case report is that of a 60-year-old female patient with underlying comorbidities including type 2 diabetes mellitus, hypothyroidism who presented with complaints of generalized weakness, weight loss, hair loss, non-resolving muco-purulent rhinorrhea, bilateral pedal edema and multiple, non-tender, firm and mobile left sided Level I and II ‘AJCC’ cervical lymphadenopathy of >2cm which was later biopsied and diagnosed to be Castleman’s disease associated POEMS syndrome. The aim of this report is to consider CD as a differential diagnosis in patients presenting with similar clinical picture and early identification and treatment may provide a better prognosis. We would also like to highlight 3 take home points: 1) The significance of histology in differentiating it from other lymph proliferative conditions. 2) LN excision of the bothersome LN can be diagnostic and may be considered therapeutic to some extend even in MCD. 3) Steroid therapy has beneficial effects to control progression of the disease.","PeriodicalId":158614,"journal":{"name":"International Journal of Clinical Oncology and Cancer Research","volume":"269 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124365313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.11648/j.ijcocr.20210604.13
P. Kechagioglou, R. Daly
{"title":"Initiating Conversations on Integrative Oncology Amongst Cancer Professionals, Integrative Medicine Practitioners and Cancer Patients – The CANCERTALK Initiative","authors":"P. Kechagioglou, R. Daly","doi":"10.11648/j.ijcocr.20210604.13","DOIUrl":"https://doi.org/10.11648/j.ijcocr.20210604.13","url":null,"abstract":"","PeriodicalId":158614,"journal":{"name":"International Journal of Clinical Oncology and Cancer Research","volume":"43 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129393016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.11648/j.ijcocr.20220702.11
Saloni Chawla, S. Thakur
{"title":"Challenges and Prospects for Providing Radiotherapy Services in Nepal","authors":"Saloni Chawla, S. Thakur","doi":"10.11648/j.ijcocr.20220702.11","DOIUrl":"https://doi.org/10.11648/j.ijcocr.20220702.11","url":null,"abstract":"","PeriodicalId":158614,"journal":{"name":"International Journal of Clinical Oncology and Cancer Research","volume":"98 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116613474","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1900-01-01DOI: 10.11648/j.ijcocr.20220702.14
Kayra Sánchez-Muñoz, José Pinto-Llerena
{"title":"Anti-EGFR–Based Treatment of Patients with Metastatic Colorectal Cancer: Data from the National Oncology Institute of Panama","authors":"Kayra Sánchez-Muñoz, José Pinto-Llerena","doi":"10.11648/j.ijcocr.20220702.14","DOIUrl":"https://doi.org/10.11648/j.ijcocr.20220702.14","url":null,"abstract":"","PeriodicalId":158614,"journal":{"name":"International Journal of Clinical Oncology and Cancer Research","volume":"44 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129890157","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：